Testing a bile-based treatment for adult encephalitis
Treatments studied
Part of Brain & nervous system, Immune system & allergy, Infections clinical trials.
This study tests a natural bile-derived medicine (Calcus Bovis Sativus) to see if it can help adults with new or recent brain inflammation (encephalitis). It focuses on people whose encephalitis is caused by the immune system or a virus, and who have not fully recovered.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with autoimmune or viral encephalitis within the last 9 months.
- For autoimmune types: your symptoms should be new or recently worsened, and you should have started your first acute treatment in the last 6 weeks.
- You cannot have an untreated tumor in your thymus or ovary (like teratoma) at the time of starting the study.
- You must be between 18 and 80 years old and willing to use contraception if you are of childbearing age.
- Your overall health should allow you to safely take part, without recent serious infections, unstable heart conditions, or other major medical problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
This study collects health information from people with autoimmune encephalitis, a condition where the body's immune system attacks the brain. It aims to understand the disease better, and if you have seizures from it, you can join a special epilepsy part.
This study is testing a new lab test that may help doctors more accurately diagnose GABABR antibody encephalitis, a type of brain inflammation. The test looks for certain antibodies in your blood or spinal fluid.
This study tests whether a nasal spray containing stem cell products can help people recover from autoimmune encephalitis, a condition where the body's immune system attacks the brain. It may reduce symptoms like confusion, memory problems, or seizures.
This study tests a new medicine (ART5803) in people whose immune system attacks a brain receptor called NMDAR, causing encephalitis (brain swelling) or psychiatric symptoms. It aims to see if the medicine can reduce symptoms like confusion, memory problems, or psychosis.
This study looks for new ways to find the cause of lymphocytic meningitis or meningoencephalitis (inflammation of the brain or its lining) when standard tests don't give an answer. It may help people who have been hospitalized with these conditions and whose spinal fluid tests were unclear or not done.
Hear when a new Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.